Identity
- Security key
- 13902
- Ticker
- CTXR
- Type
- CS — Common Stock
- Exchange
- Nasdaq(XNAS)
- Venue group
- NASDAQ
- Operating MIC
- XNAS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2011-10-18
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- CTXR
Detail
Enriched 2026-08-14 20:47
- Market cap
- $21,001,216.05
- Shares outstanding (class)
- 27,452,570
- Shares outstanding (weighted)
- 27,452,570
- SIC
- 2834 PHARMACEUTICAL PREPARATIONS
- Employees
- 23
- Location
- CRANFORD, NJ
- Homepage
- https://www.citiuspharma.com
- Description
Citius Pharmaceuticals Inc is a biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, with a focus on oncology, anti-infectives in adjunct cancer care and distinct prescription products. It aims to provide therapeutic products that address unmet medical needs yet have a lower development risk than is usually associated with new chemical entities. The company's flagship product candidate is LYMPHIR, an engineered IL-2 diphtheria toxin fusion protein. It operates through a single operating and reportable segment which is focused on developing and commercializing pioneering targeted oncology therapies.
Market cap and share counts drift.